Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT
06. Oktober 2021 10:10 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and...
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
05. Oktober 2021 12:57 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and...
Zivo Bioscience, Inc. Issues Letter to Shareholders
17. August 2021 16:05 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and...
Zivo Bioscience to Present at Two Upcoming August Conferences
11. August 2021 08:00 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic,...
Zivo Bioscience, Inc. Announces Closing of Underwriters’ Partial Exercise of Over-Allotment Option in Connection with its Previously Announced Public Offering
02. Juli 2021 08:00 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., July 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and...
ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
02. Juni 2021 09:30 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic,...
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
02. Juni 2021 09:05 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and...
ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health
26. April 2021 12:06 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of...
ZIVO Bioscience to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
11. März 2021 12:25 ET
|
Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and...